Gastrointestinal disease solutions
The company develops evidence-based solutions for gastrointestinal diseases affecting humans and animals.
Source: LinkedIn company description · Retrieved October 13, 2026
Anatara Lifesciences develops evidence-based solutions for gastrointestinal diseases in humans and animals.
GaRP is the working name for the company’s evidence-based complementary medicines, formulated with bromelain and other synergistic GRAS components. The human formulation is positioned as an adjunct to existing therapies and is being tested in a double-blinded, placebo-controlled clinical trial for safety and efficacy.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops solutions for gastrointestinal diseases in humans and animals.
The company develops evidence-based solutions for gastrointestinal diseases affecting humans and animals.
Source: LinkedIn company description · Retrieved October 13, 2026
Anatara developed Detach® to control scour (diarrhoea) in pigs; it was approved by the Australian Pesticides and Veterinary Medicines Authority.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.